Alnylam Pharmaceuticals
ALNY
#569
Rank
$43.35 B
Marketcap
$328.16
Share price
-0.93%
Change (1 day)
19.74%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company